Patents by Inventor Roger D. Cone

Roger D. Cone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DNA encoding .alpha. melanocyte stimulating hormone receptor
    Patent number: 5532347
    Abstract: The present invention relates to a mammalian melanocyte stimulating hormone receptor. The invention is directed toward the isolation, characterization and pharmacological use of mammalian melanocyte stimulating hormone receptor, the gene corresponding to this receptor, a recombinant eukaryotic expression construct capable of expressing a mammalian melanocyte stimulating hormone receptor in cultures of transformed eukaryotic cells and such cultures of transformed eukaryotic cells that synthesize mammalian melanocyte stimulating hormone receptor. The invention also provides methods for screening MSH.sup.R agonists and antagonists in vitro using preparations of receptor from such cultures of eukaryotic cells transformed with a recombinant eukaryotic expression construct comprising the MSH.sup.R receptor gene. The invention specifically provides human and mouse MSH.sup.R genes.
    Type: Grant
    Filed: April 10, 1992
    Date of Patent: July 2, 1996
    Assignee: State of Oregon, Acting by and Through the Oregon State Board of Higher Education on behalf of the Oregon Health Sciences University, a non-profit organization
    Inventors: Roger D. Cone, Kathleen G. Mountjoy
  • DNA sequence encoding bovine and human adrenocorticotropic hormone receptors
    Patent number: 5280112
    Abstract: The present invention relates to a mammalian adrenocorticotropic hormone receptor. The invention is directed toward the isolation, characterization and pharmacological use of mammalian adrenocorticotropic hormone receptor, the gene corresponding to this receptor, a recombinant eukaryotic expression construct capable of expressing a mammalian adrenocorticotropic hormone receptor in cultures of transformed eukaryotic cells and such cultures of transformed eukaryotic cells that synthesize mammalian adrenocorticotropic hormone receptor. The invention also provides methods for screening ACTH.sup.R agonists and antagonists in vitro using preparations of receptor from such cultures of eukaryotic cells transformed with a recombinant eukaryotic expression construct comprising the ACTH.sup.R receptor gene. The invention specifically provides human and bovine ACTH.sup.R genes.
    Type: Grant
    Filed: April 10, 1992
    Date of Patent: January 18, 1994
    Assignee: State of Oregon, Oregon Health Sciences University
    Inventors: Roger D. Cone, Kathleen G. Mountjoy